J Korean Soc Coloproctol.  2008 Oct;24(5):380-385. 10.3393/jksc.2008.24.5.380.

IMA-origin Lymph Node Metastasis in Left Colon Cancer

Affiliations
  • 1Department of Surgery, Yeungnam University College of Medicine, Daegu, Korea. mcshim@med.yu.ac.kr

Abstract

PURPOSE: Although an extended colon resection with high ligation of the inferior mesenteric artery (IMA) generally has been recommended as curative surgery for advanced left colon cancer (LCC), it shows little or no survival advantage over segmental resection with low ligation of IMA. The present study is to determine the risk factors associated with IMA-origin lymph-node (LN) metastasis and to clarify the implication of IMA-origin LN metastasis.
METHODS
We examined the clinicopathological results of 200 cases of LCC. LN dissection was performed as follows: D2 en-bloc resection of the primary tumor, IMA-origin LN dissection, and paraaortic LN dissection.
RESULTS
The incidence of IMA-origin LN metastasis of LCC was 4.5% (9 cases), and all cases involved sigmoid colon cancer. The independent risk factors of IMA-origin LN metastasis were four or more regional LN metastases (hazard ratio: 16.51, 95% confidence interval: 1.60~164.12) and a preoperative CEA level of greater than 6 ng/ml of (hazards ratio: 6.63, 95% confidence interval: 1.06~41.32). The incidence of IMA-origin LN metastasis among stage IIIC patients was 26.7%. Five of the 9 (55.6%) cases of IMA-origin LN metastasis had a concomitant paraaortic LN metastasis.
CONCLUSIONS
The incidence of IMA-origin LN metastasis among patients with LCC was low; however, IMA-origin LN metastasis should be considered as a systemic metastasis.

Keyword

Left colon cancer; IMA origin; Lymph node metastasis

MeSH Terms

Colon
Colonic Neoplasms
Humans
Imidazoles
Incidence
Ligation
Lymph Nodes
Mesenteric Artery, Inferior
Neoplasm Metastasis
Nitro Compounds
Risk Factors
Sigmoid Neoplasms
Imidazoles
Nitro Compounds
Full Text Links
  • JKSC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr